サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513781

胆嚢治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Gallbladder Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 235 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
胆嚢治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 235 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

胆嚢治療市場の世界需要は、2023年の955億2,000万米ドルから2032年には1,549億2,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは5.52%です。

胆嚢治療には、胆石、胆嚢炎、胆道ジスキネジアに対処するための内科的と外科的アプローチが含まれます。一般的な治療法としては、小さな胆石を溶解する薬剤療法があるが、多くの場合時間がかかり、効果もないです。最も一般的な外科的治療は胆嚢摘出術で、腹腔鏡手術または開腹手術で行われます。内視鏡的逆行性胆管膵管造影（ERCP）のような非外科的手術でも胆管の結石を取り除くことができます。治療は合併症の緩和、予防、患者の生活の質の向上に重点を置いています。

市場力学

胆嚢治療の需要は、胆石や胆嚢炎などの胆嚢に関連する疾患の有病率の上昇によって牽引されています。これらの疾患は、不健康な食生活や座りがちなライフスタイルに起因しており、一般的になりつつあります。高齢化も胆嚢治療の需要増加に寄与しています。医療技術の進歩や腹腔鏡下胆嚢摘出術のような低侵襲な手術手技により、胆嚢治療はより安全で身近なものとなり、より多くの患者が医療介入を求めるようになってきています。さらに、胆嚢疾患の認知度の向上と早期診断がタイムリーな治療と管理につながり、市場の成長をさらに促進しています。医療インフラの改善や、特に新興国における医療サービスへのアクセスの向上も、市場成長に重要な役割を果たしています。さらに、胆石のリスクを高める可能性のある肥満手術の件数が増加していることも、間接的に市場の成長を後押ししています。しかし、一部の地域では高度医療処置の費用が高く、医療へのアクセスが限られていることが、今後数年間の市場成長の課題となる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、胆嚢治療の世界市場における各セグメントを包括的に評価することもできます。胆嚢治療業界の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

胆嚢治療市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家は、今後の機会で、それぞれの製品やサービスの対象層を特定するのに役立ちます。

適応疾患別

  • 胆石症
  • 胆嚢炎と胆道疝痛
  • 胆石症と胆管結石症
  • 胆嚢ポリープ
  • 胆嚢がん

診断セグメント別

  • 超音波試験
  • 血液試験
  • コンピュータ断層撮影（CT）
  • 胆管造影
  • 肝胆膵シンチグラフィー

治療別

  • 手術
  • 薬剤
  • エンドユーザー
  • 病院と婦人科クリニック
  • 学術・研究センター

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける胆嚢治療市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブ概要

  • 市場のハイライト
  • 世界市場スナップショット

第3章 胆嚢治療-産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 胆嚢治療の世界市場分析：適応疾患別

  • 適応疾患別概要
  • 疾患適応別過去・予測データ分析
  • 胆石症
  • 胆嚢炎と胆嚢結石症
  • 胆石症と胆管結石症
  • 胆嚢ポリープ
  • 胆嚢がん

第6章 胆嚢治療の世界市場分析：診断セグメント別分析

  • 診断セグメント別概要
  • 診断セグメント別過去・予測データ分析
  • 超音波試験
  • 血液試験
  • コンピュータ断層撮影（CT）
  • 胆管造影
  • 肝胆膵シンチグラフィー

第7章 世界の胆嚢治療市場分析：治療別

  • 治療別概要
  • 治療別過去・予測データ分析
  • 手術
  • 薬剤
  • エンドユーザー
  • 病院と婦人科クリニック
  • 学術・研究センター

第8章 胆嚢治療の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 胆嚢治療企業の競合情勢

  • 胆嚢治療市場競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Boston Scientific Corporation
  • Intuitive Surgical
  • C. R. Bard. Inc.
  • Dornier MedTech
  • Koninklijke Philips N.V.
  • B. Braun Melsungen AG
  • Sanofi
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease Indications (Units and USD MN)
  • Gallstones Market Sales By Geography (Units and USD MN)
  • Cholecystitis And Biliary Colic Market Sales By Geography (Units and USD MN)
  • Cholelithiasis And Choledocholithiasis Market Sales By Geography (Units and USD MN)
  • Gallbladder Polyps Market Sales By Geography (Units and USD MN)
  • Gall Bladder Cancer Market Sales By Geography (Units and USD MN)
  • Analysis By Diagnosis Segment Analysis (Units and USD MN)
  • Ultrasound Market Sales By Geography (Units and USD MN)
  • Blood Tests Market Sales By Geography (Units and USD MN)
  • Computerized Tomography (CT) Market Sales By Geography (Units and USD MN)
  • Cholangiography Market Sales By Geography (Units and USD MN)
  • Hepatobiliary Scintigraphy Market Sales By Geography (Units and USD MN)
  • Analysis By Treatment (Units and USD MN)
  • Surgery Market Sales By Geography (Units and USD MN)
  • Drugs Market Sales By Geography (Units and USD MN)
  • End Users Market Sales By Geography (Units and USD MN)
  • Hospitals & Gynecology Clinics Market Sales By Geography (Units and USD MN)
  • Academic & Research Centers Market Sales By Geography (Units and USD MN)
  • Global Gallbladder Treatment Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gallbladder Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Gallbladder Treatment Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease Indications
  • Market Attractiveness Analysis By Diagnosis Segment Analysis
  • Market Attractiveness Analysis By Treatment
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease Indications (Units and USD MN)
  • Gallstones Market Sales By Geography (Units and USD MN)
  • Cholecystitis And Biliary Colic Market Sales By Geography (Units and USD MN)
  • Cholelithiasis And Choledocholithiasis Market Sales By Geography (Units and USD MN)
  • Gallbladder Polyps Market Sales By Geography (Units and USD MN)
  • Gall Bladder Cancer Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Diagnosis Segment Analysis (Units and USD MN)
  • Ultrasound Market Sales By Geography (Units and USD MN)
  • Blood Tests Market Sales By Geography (Units and USD MN)
  • Computerized Tomography (CT) Market Sales By Geography (Units and USD MN)
  • Cholangiography Market Sales By Geography (Units and USD MN)
  • Hepatobiliary Scintigraphy Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Treatment (Units and USD MN)
  • Surgery Market Sales By Geography (Units and USD MN)
  • Drugs Market Sales By Geography (Units and USD MN)
  • End Users Market Sales By Geography (Units and USD MN)
  • Hospitals & Gynecology Clinics Market Sales By Geography (Units and USD MN)
  • Academic & Research Centers Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112115055

The global demand for Gallbladder Treatment Market is presumed to reach the market size of nearly USD 154.92 Billion by 2032 from USD 95.52 Billion in 2023 with a CAGR of 5.52% under the study period 2024-2032.

Gallbladder treatment involves medical and surgical approaches to address gallstones, cholecystitis, and biliary dyskinesia. Common treatments include medications that dissolve small gallstones, which are often slow and ineffective. The most prevalent surgical treatment is cholecystectomy, the removal of the gallbladder, which can be done laparoscopically or through open surgery. Non-surgical procedures like endoscopic retrograde cholangiopancreatography (ERCP) can also remove stones from the bile ducts. Treatment focuses on alleviating, preventing complications, and enhancing the patient's quality of life.

MARKET DYNAMICS

The demand for gallbladder treatment is driven by the rising prevalence of gallbladder-related diseases such as gallstones and cholecystitis, which are becoming more common and attributed to unhealthy dietary habits and sedentary lifestyles. The aging population also contributes to the increased demand for gallbladder treatment, as older individuals are more susceptible to these conditions. Advancements in medical technology & minimally invasive surgical techniques, such as laparoscopic cholecystectomy, are making gallbladder treatment safer and more accessible, encouraging more patients to seek medical intervention. Additionally, increased awareness and early diagnosis of gallbladder disease lead to timely treatment and management, further driving the market growth. Healthcare infrastructure improvements and better access to healthcare services, particularly in emerging economies, also play a crucial role in market growth. Furthermore, the rising number of bariatric surgeries, which can increase the risk of gallstones, indirectly boosts the market growth. However, the high cost of advanced medical procedures and limited healthcare access in some regions may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Gallbladder Treatment. The growth and trends of Gallbladder Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Gallbladder Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease Indications

  • Gallstones
  • Cholecystitis And Biliary Colic
  • Cholelithiasis And Choledocholithiasis
  • Gallbladder Polyps
  • Gall Bladder Cancer

By Diagnosis Segment Analysis

  • Ultrasound
  • Blood Tests
  • Computerized Tomography (CT)
  • Cholangiography
  • Hepatobiliary Scintigraphy

By Treatment

  • Surgery
  • Drugs
  • End Users
  • Hospitals & Gynecology Clinics
  • Academic & Research Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Gallbladder Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Gallbladder Treatment market include Boston Scientific Corporation, Intuitive Surgical, C. R. Bard. Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi, Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GALLBLADDER TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease Indications
    • 3.7.2 Market Attractiveness Analysis By Diagnosis Segment Analysis
    • 3.7.3 Market Attractiveness Analysis By Treatment
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GALLBLADDER TREATMENT MARKET ANALYSIS BY DISEASE INDICATIONS

  • 5.1. Overview By Disease Indications
  • 5.2. Historical and Forecast Data Analysis By Disease Indications
  • 5.3. Gallstones Historic and Forecast Sales By Regions
  • 5.4. Cholecystitis And Biliary Colic Historic and Forecast Sales By Regions
  • 5.5. Cholelithiasis And Choledocholithiasis Historic and Forecast Sales By Regions
  • 5.6. Gallbladder Polyps Historic and Forecast Sales By Regions
  • 5.7. Gall Bladder Cancer Historic and Forecast Sales By Regions

6. GLOBAL GALLBLADDER TREATMENT MARKET ANALYSIS BY DIAGNOSIS SEGMENT ANALYSIS

  • 6.1. Overview By Diagnosis Segment Analysis
  • 6.2. Historical and Forecast Data Analysis By Diagnosis Segment Analysis
  • 6.3. Ultrasound Historic and Forecast Sales By Regions
  • 6.4. Blood Tests Historic and Forecast Sales By Regions
  • 6.5. Computerized Tomography (CT) Historic and Forecast Sales By Regions
  • 6.6. Cholangiography Historic and Forecast Sales By Regions
  • 6.7. Hepatobiliary Scintigraphy Historic and Forecast Sales By Regions

7. GLOBAL GALLBLADDER TREATMENT MARKET ANALYSIS BY TREATMENT

  • 7.1. Overview By Treatment
  • 7.2. Historical and Forecast Data Analysis By Treatment
  • 7.3. Surgery Historic and Forecast Sales By Regions
  • 7.4. Drugs Historic and Forecast Sales By Regions
  • 7.5. End Users Historic and Forecast Sales By Regions
  • 7.6. Hospitals & Gynecology Clinics Historic and Forecast Sales By Regions
  • 7.7. Academic & Research Centers Historic and Forecast Sales By Regions

8. GLOBAL GALLBLADDER TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE GALLBLADDER TREATMENT COMPANIES

  • 9.1. Gallbladder Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF GALLBLADDER TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Boston Scientific Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Intuitive Surgical
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. C. R. Bard. Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Dornier MedTech
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Koninklijke Philips N.V.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. B. Braun Melsungen AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Sanofi
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Others
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies